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Abstract During the last decade, Clostridium difficile
infection (CDI) increased markedly inside as well as
outside of hospitals. In association with the occurrence of
new hypervirulent C. difficile strains, CDI became more
important. Until now typing of C. difficile strains has been
enabled by PCR-ribotyping. However, this method is
restricted to specialized laboratories combined with high
maintenance cost. Therefore, we tested MALDI-TOF mass
spectrometry for typing of C. difficile to provide a fast
method for surveillance of CDI. Using a standard set of 25
different C. difficile PCR ribotypes a database was made by
different mass spectra recorded in the SARAMIS™
software (AnagnosTec, Zossen, Germany). The database
was validated with 355 C. difficile strains belonging to 29
different PCR ribotypes collected prospectively from all
submitted feces samples in 2009. The most frequent PCR
ribotypes were type 001 (70%), 027 (4.8%) and 078/126
(4.7%). All three types were recognized by MALDI-TOF
MS. We conclude that an extended MALDI-TOF system
was capable to recognize specific markers for ribotypes
001, 027 and 078/126 allowing an effective identification
of these strains.
Introduction
In recent years the number of Clostridium difficile
infections (CDI) increased markedly in hospitals (hospital-
acquired CDI) as well as outside hospitals (community-
acquired CDI). Since 2003, hypervirulent strains of
C. difficile belonging to PCR ribotypes 078 and 027 have
been found in North America and in Western Europe. Due
to higher toxin production of C. difficile 027, infections
result in increased mortality [1].
Until now PCR-ribotyping has been the most effective
and widely accepted molecular tool for typing of C. difficile
strains. This provides the possibility of monitoring CDI
outbreaks and the occurrence of hypervirulent strains.
Today matrix assisted laser desorption/ionization-time of
flight mass spectroscopy (MALDI-TOF MS) provides an
easy to handle system in order to identify different bacterial
pathogens including C. difficile [2, 3]. MALDI-TOF MS is
actually utilizable for determination of the bacterial species.
There are only a few reports suggesting that MS can be
applied for typing of MRSA [4, 5], C. difficile [6]
Legionella [7, 8] and Pseudomonas [9].
We performed classical PCR-ribotyping of different
C. difficile strains as well as typing via the extended
SARAMIS™ MALDI-TOF system and found specific
markers for ribotypes 001, 027 and 126/078 allowing
clonal identification. Here we report on typing of the
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Patients and methods
Laboratory and hospital settings
Synlab Medical Care Centre (Weiden, Germany) is located
in a rural area in Southern Germany and analyses clinical
samples from about 40 hospitals and more than 2,000
physicians serving outpatients in Northern Bavaria [10]. In
this region, CDI is known as an increasing nosocomial
problem with sporadic severe cases [10, 11, 12].
In the first half of 2009 we cultured approximately 500
C. difficile isolates from stool samples derived from in- and
outpatients known with positive C. difficile toxin (Tcd) tests
of stools.
Epidemiologic analysis of C. difficile in South Germany
Numbers of Tcd-positive stool samples and numbers of
performed Tcd-tests were evaluated by the Hybase system
(Cymed AG, Bochum, Germany) linked to the laboratory
data system “promed open” (MCS, Eltville, Germany) as
described before [10].
C. difficile toxin analysis and culture
Stool samples were collectedd u r i n g2 0 0 9a n dt e s t e df o r
C. difficile. Tcd examination and culture of C. difficile
were performed as previously described [11].
Identification of C. difficile was performed using the
identification system for anaerobes “rapid ID 32 A system”
(Biomérieux, Nürtingen, Germany) and by MALDI-TOF
MS using the Bruker Daltonics microflex LT system
(Bruker Daltonik GmbH, Bremen, Germany).
PCR ribotyping
After extraction of bacterial DNA, amplification reactions
were performed with specific primers according to Bidet
et al. [13]. In variation to this protocol, amplification
reactions were performed in a 26.5 μl volume containing
15 μlH 2Obidest.,2 . 6μl 10× FastStart Taq Polymerase
PCR-buffer + MgCl2 (Roche), 1.25 μlo fe a c hp r i m e r ,
0.25 μl dNTP (20 mM, Pharmacia), 0.15 μl FastStart Taq
DNA polymerase (5 U/μl, Roche) and 6 μl template DNA.
PCR was performed in a thermal cycler, for 1 cycle of
360 s at 95°C for initial denaturation and 40 cycles of
denaturation at 95°C for 30 s, annealing at 55°C for 30 s
and extension at 72°C for 45 s. Final extension was carried
out for 180 s at 72°C.
Detection of PCR products
Amplification products were separated using 8% polyacryl-
amide gels (for 2.5 h at 80 V, 21 mA in 1× TBE buffer).
DNA banding patterns were visualized on a UV-
transilluminator (Sigma) after staining for 15 min in
ethidium bromide (20 μg/ml) and destaining for 5 min in
H2Obidest. A molecular mass standard (DNA molecular
weight marker VI, Roche) was included for normalization
of the gel patterns. PCR ribotype profiles were compared to
band patterns of 25C. difficile reference strains (Cardiff-
ECDC collection). C. difficile isolates that did not match
one of the reference strains were sent for further typing to
the German Reference Laboratory for Gastrointestinal
Infections (University of Freiburg, Freiburg, Germany) or
to Leiden University Medical Center (LUMC, Leiden, The
Netherlands).
AXIMA@SARAMIS™ MALDI-TOF MS
MALDI-TOF MS for typing of C. difficile was performed
in the laboratory of AnagnosTec Association for analytical
biochemistry and diagnostics mbH (Zossen, Germany)
according to the internal standard operating procedure.
After anaerobic cultivation of C. difficile isolates and
examination of the culture morphology and purity,
respective cells were transferred from blood-agar plates
after 24 h growth at 37°C to a free spot on the FlexiMass-
DS target using the direct smear method. Then, 1.0 μl
alpha-cyano-4-hydroxy cinamic acid (CHCA) matrix
solution was added to the samples within less than two
minutes after transferring of cells to the target. The matrix
solution (saturated CHCA in 33% ethanol, 33% aceto-
nitrile, 3% triflouro acetic acid and 31% water)
extracted the proteins. Afterwards, the matrix was dried
at room temperature on the bench (not under air flow).
Finally, the target was inserted into the mass spectrom-
eter and spectra were generated by double-measurement
with adequate quality control criteria. Mass analyses
were performed in the linear mode with delayed,
positive ion delayed extraction (acceleration voltage:
20 kV) on an AXIMA Confidence (Shimadzu Europe,
Duisburg, Germany) mass spectrometer equipped with a
nitrogen laser (l=337 nm). Spectra were accumulated
from 500 automatically acquired laser pulse cycles. All
spectra were processed by the BioTech Launchpad
software (Shimadzu Europe, Duisburg, Germany) with
baseline correction, peak filtering and smoothing. The
resulting peak lists were exported to the SARAMIS™
software package. The spectra were compared to the
superspectra for species identification. All spectra were
transferred into the database for cluster analysis and
biomarker analysis (Table 1).
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Development of a MALDI-TOF database using
ECDC-Brazier collection
Using the ECDC-Brazier collection encompassing 25
different PCR ribotypes we developed an initial reference
database. After recording the mass spectra of each isolate
by AXIMA@SARAMIS™ MALDI-TOF MS the data were
stored along with the information of PCR ribotypes in a
SARAMIS™ database (Spectral Archive and Microbial
Identification System). An internal calculation algorithm
(Superspectra™ function for selection of specific bio-
markers) was applied to recognize if certain peaks or
combinations of certain peaks might be associated with
specific PCR ribotypes. After identification of frequently
occurring masses indicative for a certain subtype, it was
examined how many “indicative masses” have to be
determined in combination with the system to automatically
recognize the respective ribotype. Masses of ribosomal
protein fragments observed by MALDI-TOF MS analyses
applied to the 25 reference PCR ribotypes are summarized
in Table 1. Using this database, four individual PCR
ribotypes could be recognized (Table 1). Types other than
001, 027 and 078/126 could not be separated due to the
lack of specific masses.
Results of the analysis of 355 German clinical isolates
Ribotyping was performed on 355 C. difficile isolates,
collected in the first half of 2009, revealing 29 different
ribotypes. At least 330 isolates were clinical isolates from
patients. Our C. difficile collection from patients showed
the following constitution:
Ribotype (RT) 001 (n=248; 70.0%) was the most prevalent
strain, followed by RT 027 (n=17; 4.8%), RT 078, 015 (n=7;
2.0%), RT 126 (n=6;2.7%),RT095(n=5;1.4%),RT77(n=
4; 1.1%), RT 003, 014, 017, 023, (n=3; 0.9%), RT 002, 029,
045, 046, 070, 081, 149 (n=2; 0.6%), and RT 005, 012, 020,
053, 056, 075, 087, 106, 117, 131 (n=1; 0.3%).
Figure 1 shows spectra representative for the most
common strains 001, 027 and 126/078. Stars show
indicative masses for the respective ribotype.
Validation of the MALDI-TOF MS database with 355
German isolates
On the basis of the specific masses found for ribotypes 001,
027 and 078/126 (see Table 1) we verified our database on
the collected German isolates. While masses in yellow
fields were not indicative for the given strains, masses in
green fields were indicative for C. difficile 001 (n=248),
masses in magenta fields for C. difficile 027 (n=17) and
masses in blue fields for C. difficile 126/078 (n=6/7).
All 001 isolates (n=248) were recognized by the
presence of 9–18 of the “green masses”. The definition of
less than nine masses resulted such that strains other than
001 were erroneously matched to C. difficile 001 while
determination of more than 18 masses resulted in dis-
regarding 001 isolates.
To identify 027 isolates, definition of the three “magenta
masses” was sufficient using ten strains of ribotypes 027.
Table 1 Number of tested C. difficile isolates (double measurement) and distribution of the detected masses
Ribotyp RT001 RT002 RT003 RT012 RT014 RT015 RT017 RT020 RT023 RT027 RT029 RT046 RT053 RT056 RT070 RT075 RT077 RT078 RT081 RT087 RT095 RT106 RT117 RT126 RT131
mass m/z n 498 4 4 2 6 6 6 2 6 36 6 2 2 2 4 2 6 17 4 2 5 2 2 29 2
3 3 6 11 9 2 1 2 9 00225320 1 4 3121110811122 1 0 1
3453 155 136 12111001500200020101001 0
3546 304 222 01021103 1 3 2220112 1 7 20102 2 9 0
3 7 6 22 5 3 1 7 9 30042112 1 6 4121125720222 1 3 1
3939 238 187 0 0 2 2 2 4 0 4 12 5 00021233011142
3988 229 145 10033212 2 5 5211222 1 1 30400 1 2 2
4 2 4 72 5 9 2 1 7 31041204 1 0 501012111100031
4 3 2 52 9 4 2 3 5 1100340434021311 1 2 21200 1 3 1
4 3 9 62 0 8 2 0 2 000000003000000100000020
4 6 5 52 0 9 1 4 3 20125311 1 5 501122273031072
4679 191 127 0 2 2 1 6 3 1 0 12 3 221110731222 1 0 0
4876 186 163 100101025201101022020020
4 9 3 0 3 0 000000000 2 8 000000010000010
5257 8 74 1 0112000020200002 1 5 11110 1 7 0
5298 1 2 54 8 2004422036201000 1 5 42422 2 1 1
5 3 0 9 3 5 200001000 3 0 000000010000010
5 4 1 82 9 0 2 4 4 320332007102122432000072
5455 221 190 232011124101012410100040
5695 236 157 3 2 1 2 4 2 2 3 28 6 10212603132212
6 2 2 22 3 6 2 0 2 221001015101021301112171
6 3 9 02 6 6 2 2 2 2102020383120110510001 1 1 0
6580 5 51 0 0002000020200000 1 7 00000 2 2 0
6707 26 500000200 1 9 000000000000000
6 9 0 82 5 2 2 1 4 210122023202012434000070
7092 215 140 0103010482211101 1 7 20001 2 9 1
7155 229 180 2102130340211202901000 1 5 0
7551 174 145 012122016100110002030051
7851 261 203 2120432234020121722012 1 3 2
8084 3 1 60001000000000000700000 1 7 0
8401 4 4 30002000000100000 1 5 00000 2 3 0
8 8 4 32 3 9 2 0 7 00002000 2 7 000000100200000
9735 193 159 121022123301111122112130
11202 4 4 20002000000200000 1 5 00000 2 3 0
green specific masses of PCR-ribotype 001, magenta specific masses of PCR-ribotype 027, blue specific masses of PCR-ribotypes 078 and 126,
yellow highly frequent masses among sporadic strains, RT ribotype, m/z mass-to-charge-relation
Eur J Clin Microbiol Infect Dis (2011) 30:1431–1436 1433Fig. 1 Overview of the mass
spectra of C. difficile
PCR-ribotypes 001 (A), 027 (B)
and 126/078 (C) in comparison
to the mass spectrum of
Clostridium orbiscindens (D).
Each peak represents the mass
of an intact protein detected in
the analyses while the height of
the peak depends on the amount
of proteins measured. Specific
masses are indicated by stars.
RT ribotype, Int. intensity, m/z
mass-to-charge-relation
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Robert-Koch-Institute (n=7) were also correctly identified.
Because of the high molecular similarity of ribotype 126
and the hypervirulent strain 078, only PCR-ribotyping was
able to discriminate between these two strains. Generated
mass spectra of ribotypes 126 and 078 showed that both
strains share seven specific “blue masses”. Thus, typing of
ribotypes 126 and 078 was sufficient for verification of the
group of ribotypes 126/078.
Recently it was noticed that C. difficile strains 001, 017
and 027 were associated with fatal outcome in Germany
[14]. As demonstrated here, strains 001 and 027 might be
identified simultaneously to C. difficile identification when
using MALDI-TOF MS. However, due to the low number
of 017 isolates it was not possible to identify diagnostic
peaks for this strain. Although this limitation counts for
other sporadic strains found in our region, 98.9% of the
isolates(268of271)belongingtotypes 001,027and078/126
were identified correctly by MALDI-TOF MS.
However, the finding that most strains were isolated only
sporadically (<10 isolates per strain per 6 months) implies
that it was not possible to determine specific masses for
these strains. On the other hand, in a population exhibiting
a different composition of C. difficile strains, strains other
than 001, 027 and 126 might be isolated in high numbers
probably allowing strain identification by MALDI-TOF
MS. Consequently, and besides technical conditions,
identification of C. difficile strains by MALDI-TOFMS
also depends on the prevalence of certain strains within a
region.
However, one observation limits usage of our settings
for application in other regions. Although the 027 isolates
from the Robert-Koch-Institute were correctly identified
when using 027 identification criteria (e.g. the three
magenta masses), they also shared masses of ribotype
001. The 027 isolates (n=7) from the Robert-Koch Institute
derived from regions other than Northern Bavaria in
Germany indicating regional specificity of C. difficile
MALDI-TOF MS spectra. Hence, determination of regional
settings for C. difficile strain identification by MALDI-TOF
MS is essential. Furthermore, it also seems necessary to
monitor strain identifica t i o nb yb o t hM A L D I - T O FM S
and ribotyping over time to notice variation of spectra of
C. difficile strains.
Analysing C. difficile by the Bruker Daltonics microflex
LT system (Bruker Daltonik GmbH, Bremen, Germany)
resulted in correct species identification. However, in our
laboratory it was not possible to identify different ribotype
strains. Recently, preliminary results of a study have been
presented in which the Bruker system correctly recognized
C. difficile PCR ribotypes 027 and 078 after composition of
a new database encompassing at least ten spectra of each
type [6].
We were able to type C. difficile isolates using an
extended MALDI-TOF MS system and we identified
specific markers for the most frequent C. difficile ribotype
001 in Southern Germany including the highly virulent
strain NAP1/027. However, typing of other, more sporadic
strains was not possible due to the lack of sufficient
numbers of C. difficile isolates. In order to use this effective
system for typing of more sporadic strains as well, future
work will have to analyze more isolates of the respective
ribotypes to generate a broad database of reference mass
spectra. In the end, MALDI-typing will provide a suitable
tool for C. difficile strains and surveillance of CDI.
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